Your browser doesn't support javascript.
loading
Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
Fernandes, Lorenzo M; Tresemer, Jeffrey; Zhang, Jing; Rios, Jonathan J; Scallan, Joshua P; Dellinger, Michael T.
Afiliación
  • Fernandes LM; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.
  • Tresemer J; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.
  • Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, United States.
  • Rios JJ; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, TX, United States.
  • Scallan JP; McDermott Center for Human Growth and Development, Dallas, TX, United States.
  • Dellinger MT; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Front Cell Dev Biol ; 11: 1276333, 2023.
Article en En | MEDLINE | ID: mdl-37842094
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos